BECN1 and cerebral toxoplasmosis: Taken together, Saracatinib triggered accumulation of PTEN around tachyzoites in neural tissue reducing expression of phospho-S473 Akt, triggered marked reduction in parasite load and induced protection against ocular and cerebral toxoplasmosis that were dependent on Beclin 1.